Therapeutics and Clinical Risk Management 2014:10 197–205 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Therapeutics and Clinical Risk Management 2014:10 475–478 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Tomasz Gaszynski
Correspondence Tomasz Gaszynski

August 2016

C a s e s e R i e s open access to scientific and medical research Open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 851–860 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Ana Paula Klein
Ana Paula
Botelho Gualda
Rajendranath Ramasawmy
Fábio Francesconi
Correspondence Fábio Francesconi

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 615–620 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Ebru Çelik Kavak
Ismail Demirel
Raşit Ilhan
Correspondence Salih Burcin Kavak

August 2016

C a s e s e R i e s open access to scientific and medical research Open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 17–26 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Lu-shan Yu
Su Zeng
Yu-wen Huang
Hui-min Xu
Quan Zhou
Correspondence Quan Zhou

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 87–94 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Sriya Ranatunga
Anne V Miller
Correspondence Sriya Ranatunga

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 255–257 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Berglind Libungan
Christian Dworeck
Correspondence Berglind Libungan

August 2016

C a s e R e p o RT open access to scientific and medical research open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 737–741 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Chunyu Zhang
Jiaoying Cheng
Yan Jiang
Junyang Liu

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 621–629 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Naoki Aikawa
Yasushi Kawasaki

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 259–268 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Roberto Casale
Consalvo Mattia
Correspondence Roberto Casale

August 2016

E x p E RT O p i n i O n open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 395–404 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Joshua R Colombo
Richard O Wein
Correspondence Joshua
R Colombo

September 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 355–362 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Daniel Schneiderbanger
Stephan Johannsen
Norbert Roewer
Frank Schuster
Correspondence Frank Schuster

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 313–320 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Chadi Rakieh
Philip G Conaghan

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 597–602 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Mauricio Danckers
William N Rom

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 775–786 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Hon K Yuen
Melissa A Cunningham

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 567–576 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Artur Dziewierz
Tomasz Rakowski
Dariusz Dudek
Correspondence Artur Dziewierz

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 475–478 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Tomasz Gaszynski
Correspondence Tomasz Gaszynski

August 2016

C a s e s e R i e s open access to scientific and medical research Open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 851–860 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Ana Paula Klein
Ana Paula
Botelho Gualda
Rajendranath Ramasawmy
Fábio Francesconi
Correspondence Fábio Francesconi

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 615–620 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Ebru Çelik Kavak
Ismail Demirel
Raşit Ilhan
Correspondence Salih Burcin Kavak

August 2016

C a s e s e R i e s open access to scientific and medical research Open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 17–26 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Lu-shan Yu
Su Zeng
Yu-wen Huang
Hui-min Xu
Quan Zhou
Correspondence Quan Zhou

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 87–94 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Sriya Ranatunga
Anne V Miller
Correspondence Sriya Ranatunga

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 255–257 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Berglind Libungan
Christian Dworeck
Correspondence Berglind Libungan

August 2016

C a s e R e p o RT open access to scientific and medical research open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 737–741 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Chunyu Zhang
Jiaoying Cheng
Yan Jiang
Junyang Liu

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 621–629 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Naoki Aikawa
Yasushi Kawasaki

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 259–268 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Roberto Casale
Consalvo Mattia
Correspondence Roberto Casale

August 2016

E x p E RT O p i n i O n open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 395–404 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Joshua R Colombo
Richard O Wein
Correspondence Joshua
R Colombo

September 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 355–362 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Daniel Schneiderbanger
Stephan Johannsen
Norbert Roewer
Frank Schuster
Correspondence Frank Schuster

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 313–320 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Chadi Rakieh
Philip G Conaghan

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 597–602 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Mauricio Danckers
William N Rom

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 775–786 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Hon K Yuen
Melissa A Cunningham

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 567–576 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Artur Dziewierz
Tomasz Rakowski
Dariusz Dudek
Correspondence Artur Dziewierz

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 475–478 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Tomasz Gaszynski
Correspondence Tomasz Gaszynski

August 2016

C a s e s e R i e s open access to scientific and medical research Open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 851–860 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Ana Paula Klein
Ana Paula
Botelho Gualda
Rajendranath Ramasawmy
Fábio Francesconi
Correspondence Fábio Francesconi

August 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Therapeutics and Clinical Risk Management 2014:10 615–620 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Ebru Çelik Kavak
Ismail Demirel
Raşit Ilhan
Correspondence Salih Burcin Kavak

August 2016

C a s e s e R i e s open access to scientific and medical research Open access Full Text articl

Therapeutics and Clinical Risk Management 2014:10 197–205 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Abstract

Extracted data

Therapeutics and Clinical Risk Management 2014:10 197–205 Therapeutics and Clinical Risk Management Dovepress submit your manuscript | www.dovepress.com

Abstract

Extracted data

Related items

Related items